You are here: Industry Insights > API

News List

Angelini Fine Chemicals Invests in Flow Chemistry & Micro-Reaction Technology contractpharma
May 13, 2021
A confluence of factors is driving the need for a paradigm shift in pharmaceutical manufacturing strategies in order to accelerate R&D pipeline to market.
Carbogen Amcis signs co-funding pact worth over CHF 15 million to expand Swiss site expresspharma
April 30, 2021
Carbogen Amcis will produce exclusively for the signatory customer a complex highly potent drug component for a commercial antibody-drug-conjugate API.
Collaboration to encourage US adoption of continuous manufacturing europeanpharmaceuticalreview
April 14, 2021
USP and Phlow have built a new laboratory to develop test methods and standards to facilitate broader adoption of continuous manufacturing in the US.
Solara Active Pharma and Aurore Life Sciences merge to create pure-play API/CRAMs company expresspharma
April 12, 2021
The Board of Directors of Solara Active Pharma Sciences accepted the recommendations of the Committee of Independent Directors and Audit Committee and approved the amalgamation of Aurore, Empyrean and Hydra with Solara.
Centre bans exports of remdesivir until COVID situation gets better expresspharma
April 12, 2021
In view of increased demand for remdesivir due to a surge in COVID-19 cases, the Centre said the export of the antiviral injection and its Active Pharmaceutical Ingredients (API) has been banned till the situation improves.
Asymchem Expands Oligonucleotides Mfg. Capacity contractpharma
March 29, 2021
API facility in Tianjin, China will accommodate gram to ton production scales with capacity to accommodate 12 or more oligo process production lines.
Govt. set to introduce single-window clearance for investors by Apr15: DPIIT Secy expresspharma
March 26, 2021
The single-window portal will integrate the existing clearance systems of various central and state departments.
Pharma MSMEs seek government intervention to tackle shortage, price increase of raw materials expresspharma
March 17, 2021
Caution that if the situation continues, there could be a scarcity of medicines in the country.
C2 PHARMA Completes Multiple Regulatory Filings, Expands API Portfolio to Solidify Position as a Leading Ophthalmic API Supplier to the Pharmaceutical Industry PharmaSources.com
February 24, 2021
Luxembourg, February 23, 2021 – C2 PHARMA, a pharmaceutical group established in 2014 focused on niche active pharmaceutical ingredient (APIs), has expanded its portfolio of APIs and botanical extracts throughout 2020.
Cascade Chemistry Initiates Expansion of cGMP Manufacturing Capacity americanpharmaceuticalreview
February 23, 2021
Cascade Chemistry announced initiation of construction of new facilities designed to increase the company’s capacity to manufacture APIs (active pharmaceutical ingredients) under cGMP (current Good Manufacturing Practices standards and procedures).